Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Return on Sales (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Return on Sales for 5 consecutive years, with 2.5% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 2194.0% to 2.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.5% through Dec 2025, up 2194.0% year-over-year, with the annual reading at 71.21% for FY2011, 5047.0% down from the prior year.
  • Return on Sales for Q4 2025 was 2.5% at Lexicon Pharmaceuticals, down from 0.86% in the prior quarter.
  • The five-year high for Return on Sales was 0.13% in Q2 2025, with the low at 36.4% in Q3 2024.